Figure 1: Summary of hematology laboratory shifts from baseline in the study population. The number of patients with a given shift tended to be lowest for patients receiving HPβCD-diclofenac and placebo. Shift to high = shift from normal or low value at screening to a high value during study. Shift to low = shift from normal or high value at screening to a low value during study. Hematocrit was measured in %, hemoglobin in g/L, and platelet count in 109/L. For each measurement, the total number of patients (HPβCD-diclofenac, ketorolac, placebo) was as follows: hematocrit (277, 124, 121); hemoglobin (279, 125, 121); platelets (274, 124, 120).